Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
Quanta System
  • Press ReleasesTechnology

Quanta System Inc. Expands U.S. Operations to Drive Surgical Innovation

  • The Pharma Data
  • February 28, 2026

Quanta System Establishes U.S. Entity to Enhance Market Responsiveness and Customer Engagement Why is the U.S. market pivotal for Italian companies in the medical technology sector? Quanta System Sp.A., a…

Read MoreQuanta System Inc. Expands U.S. Operations to Drive Surgical Innovation
VTAMA Cream
  • Regulatory

VTAMA Cream Shows Early and Consistent Sleep Improvements in Pediatric Atopic Dermatitis

  • The Pharma Data
  • February 28, 2026

Organon Presents Data on VTAMA Cream’s Impact on Sleep at AAAAI 2026 Annual Meeting How can we address the significant sleep disturbances that affect children with atopic dermatitis and their…

Read MoreVTAMA Cream Shows Early and Consistent Sleep Improvements in Pediatric Atopic Dermatitis
BlueWind Medical
  • News

BlueWind Medical Sets New Standard in Implantable Tibial Neuromodulation with Revi® System

  • The Pharma Data
  • February 28, 2026

Three-Year Data Confirm Revi’s Unmatched Durability and Patient Satisfaction Why is the treatment of urgency urinary incontinence (UUI) still a significant challenge for healthcare providers? BlueWind Medical, a leader in…

Read MoreBlueWind Medical Sets New Standard in Implantable Tibial Neuromodulation with Revi® System
Guardant Health
  • Press Releases

Sun Nuclear Launches Daily QA 4 Pro at 15th QA & Dosimetry Symposium in Rome

  • The Pharma Data
  • February 28, 2026

Sun Nuclear Introduces Daily QA 4 Pro to Enhance Machine Quality Assurance in Cancer Care Why is the future of cancer care quality and patient safety becoming increasingly critical for…

Read MoreSun Nuclear Launches Daily QA 4 Pro at 15th QA & Dosimetry Symposium in Rome
ImmunityBio
  • Research

ImmunityBio Completes Enrollment in Phase 2 ANKTIVA® Trial for Bladder Cancer

  • The Pharma Data
  • February 27, 2026

Promising Results for BCG-naïve NMIBC Patients Why are new treatment options for non-muscle invasive bladder cancer (NMIBC) crucial for patient outcomes? ImmunityBio a commercial-stage immunotherapy company, has completed enrollment in…

Read MoreImmunityBio Completes Enrollment in Phase 2 ANKTIVA® Trial for Bladder Cancer
Evox
  • Press Releases

Evox Therapeutics Partners with RSRT to Develop Gene Editing Treatment for Rett Syndrome

  • The Pharma Data
  • February 27, 2026

Collaboration Aims to Overcome Delivery Challenges for Neurological Disorders Why has gene editing for Rett syndrome remained elusive despite its potential to reverse symptoms? Evox Therapeutics Ltd (Evox), a biotechnology…

Read MoreEvox Therapeutics Partners with RSRT to Develop Gene Editing Treatment for Rett Syndrome
Zai Lab
  • News

Zai Lab Reports Strong 2025 Financials and Advances Global Oncology Pipeline

  • The Pharma Data
  • February 27, 2026

Zai Lab’s 2025 Revenue Grows 17% YoY, Paving the Way for 2026 Oncology and Immunology Milestones What does the future hold for global oncology and immunology advancements? Zai Lab Limited…

Read MoreZai Lab Reports Strong 2025 Financials and Advances Global Oncology Pipeline
ViiV Healthcare
  • Business

ViiV Healthcare Unveils Promising Long-Acting HIV Treatments with VH184 and VH499

  • The Pharma Data
  • February 27, 2026

New Data Show Potential for Twice-Yearly Dosing, Enhancing Treatment Options for HIV Patients Why is the current landscape of HIV treatment ripe for innovation? ViiV Healthcare, a global specialist HIV…

Read MoreViiV Healthcare Unveils Promising Long-Acting HIV Treatments with VH184 and VH499
Niagen Bioscience
  • RegulatoryNews

Niagen Bioscience Strengthens IP Moat with New Patent for NAD+ IV and Injectable Formulations

  • The Pharma Data
  • February 26, 2026

Patent Expands Niagen’s Leadership in NAD+ Delivery, Supporting Faster and Safer Treatments Why is the race for intellectual property in the NAD+ market heating up? Niagen Bioscience, Inc. a global…

Read MoreNiagen Bioscience Strengthens IP Moat with New Patent for NAD+ IV and Injectable Formulations
  • Research

Atlanta Hawks and Ressler Gertz Family Foundation Donate $150,000 to Prostate Cancer Research

  • The Pharma Data
  • February 26, 2026

Hawks and Ressler Gertz Family Foundation Boost Prostate Cancer Research with $150,000 Donation Why is prostate cancer awareness and research crucial in the sports industry? The Atlanta Hawks Foundation, in…

Read MoreAtlanta Hawks and Ressler Gertz Family Foundation Donate $150,000 to Prostate Cancer Research
Alpha
  • News

Alpha Cognition Enrolls First Patient in BEACON Study for ZUNVEYL

  • The Pharma Data
  • February 26, 2026

Real-World Impact of ZUNVEYL in Long-Term Care to Be Assessed What does the future hold for Alzheimer’s disease treatment in long-term care settings? Alpha Cognition Inc. a biopharmaceutical company focused…

Read MoreAlpha Cognition Enrolls First Patient in BEACON Study for ZUNVEYL
NYU Abu Dhabi
  • Regulatory

NYU Abu Dhabi and RTW Investments Partner to Advance Healthcare Innovation in the Middle East

  • The Pharma Data
  • February 26, 2026

Strategic Collaboration to Convene Global Investors and Leaders for Healthcare Advancement Why is the Middle East emerging as a critical hub for healthcare innovation? NYU Abu Dhabi and RTW Investments,…

Read MoreNYU Abu Dhabi and RTW Investments Partner to Advance Healthcare Innovation in the Middle East
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Agenus Publishes Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Liver Cancer
  • Lantern Pharma Announces First Quarter 2026 Financial Results and Corporate Updates
  • Genentech Wins FDA Approval for Tecentriq in ctDNA-Guided Adjuvant Treatment of Muscle-Invasive Bladder Cancer
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.